The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population
Open accessAbstract
Objective : To evaluate the incidence of discontinuation of and changes in treatment after newly prescribed courses of antihypertensive drugs of the four primary therapeutic classes: ß blocker, calcium channel blocker, and angiotensin converting enzyme inhibitor. Design : A retrospective analysis of patients on an automated database of 1.2 million patients was conducted on visits between 1 October 1992 and 30 September 1993. Setting : General practices in the United Kingdom. Subjects : 37643 patients with hypertension receiving a relevant drug in the time period were identified. A new course of treatment in at least one of the four therapeutic classes, defined as a drug not prescribed in the previous four months, was observed in 10222 patients aged >/=40 years. Main outcome measures : Patients changing to other treatment or discontinuing after initiating a new course of treatment, defined as the absence of a refill prescription for the new drug or another in its category within a six month observation period. Results : Changes in or discontinuation of treatment were frequently observed, and by month six continuation rates ranged between 40% to 50% for all four classes of drugs. Conclusion : Low rates of continuation with a newly prescribed antihypertensive drug exist regardless of which drug is prescribed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effects of Antihypertensive Therapy on the Quality of Life
Croog, S. H., Levine, S., Testa, M. A., Brown, B., Bulpitt, C. J., Jenkins, C. D., Klerman, G. L., & Williams, G. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142602 · Cited by 1,325
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 611
Berendsen, A. A. M., Kang, J. H., van de Rest, O., Jankovic, N., Kampman, E., Kiefte-de Jong, J. C., Franco, O. H., Ikram, M. A., Pikhart, H., Nilsson, L. M., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000464269 · Cited by 562
Increased Absenteeism from Work after Detection and Labeling of Hypertensive Patients
Haynes, R. B., Sackett, D. L., Taylor, D. W., Gibson, E. S., & Johnson, A. L. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991403 · Cited by 510
Psaty, B. M. (1990) · JAMA · doi:10.1001/jama.263.12.1653 · Cited by 268
The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population
McCombs, J. S., Nichol, M. B., Newman, C. M., & Sclar, D. A. (1994) · Medical Care · doi:10.1097/00005650-199403000-00003 · Cited by 187
Underutilization of Antihypertensive Drugs and Associated Hospitalization
Maronde, R. F., Chan, L. S., Larsen, F. J., Strandberg, L. R., Laventurier, M. F., & Sullivan, S. R. (1989) · Medical Care · doi:10.1097/00005650-198912000-00007 · Cited by 104
Compliance to Treatment for Hypertension in Elderly Patients: The Shep Pilot Study
Black, D. M., Brand, R., Greenlick, M. R., Hughes, G., & Smith, J. J. B. (1987) · Journal of Gerontology · doi:10.1093/geronj/42.5.552 · Cited by 87
Temporal Patterns of Antihypertensive Medication Use Among Elderly Patients
Psaty, B. M. (1993) · JAMA · doi:10.1001/jama.1993.03510150071032 · Cited by 62
Correlates of attendance and compliance in the hypertension detection and follow-up program
Shulman, N. B., Cutter, G., Daugherty, R. M., Sexton, M. J., PAUK, G. L., Taylor, M. J., & Tyler, M. D. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90016-2 · Cited by 54
Pharmacological treatment of hypertension
Swales, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91405-2 · Cited by 53
Cited by
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Structure-based design of aliskiren, a novel orally effective renin inhibitor
Wood, J. M., Maibaum, J., Rahuel, J., Grütter, M. G., Cohen, N.-C., Rasetti, V., Rüger, H., Göschke, R., Stutz, S., Fuhrer, W., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01451-7 · Cited by 506
Unintentional non-adherence to chronic prescription medications: How unintentional is it really?
Gadkari, A. S., & McHorney, C. A. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-98 · Cited by 378
Medication Non-Adherence in the Elderly: How Big is the Problem?
Hughes, C. M. (2004) · Drugs & Aging · doi:10.2165/00002512-200421120-00004 · Cited by 340
Continuation of initial antihypertensive medication after 1 year of therapy
Bloom, B. S. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80130-6 · Cited by 298
Metadata
- Authors
- Jones, J. K., Gorkin, L., Lian, J. F., Staffa, J. A., & Fletcher, A. P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1995-07-29
- Volume
- 311
- Issue
- 7000
- Pages
- 293-295
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2083126683
- Cited by
- 258
- References
- 14
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.